How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway
| Autor: | Igland, Jannicke, Forster, Rachel Bedenis, Jenum, Anne Karen, Strandberg, Ragnhild Bjarkøy, Berg, Tore Julsrud, Røssberg, Jan Ivar, Iversen, Marjolein M., Buhl, Esben Selmer |
|---|---|
| Zdroj: | Igland, Jannicke Forster, Rachel Bedenis Jenum, Anne Karen Strandberg, Ragnhild Bjarkøy Berg, Tore Julsrud Røssberg, Jan Ivar Iversen, Marjolein M. Buhl, Esben Selmer . How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway. BMJ Open. 2024, 14(3) BMJ Open |
| Databáze: | NORA (Norwegian Open Research Archive) |
| Externí odkaz: |
|